Carlos Nunez discusses how big data is generating fast, efficient insights into the real-world therapy experience of patients with SDB. Big tech companies are interested in its potential to improve treatment and adherence – how about you?
Real world evidence: recent big data insights into SDB treatment and the need for tailored SDB therapy
- ERS INTERNATIONAL CONGRESS 2019
- THE POWER OF BIG DATA TO GENERATE INSIGHTS ON VAST COHORT OF PATIENTS
- THE MOST RECENT BIG DATA PUBLICATIONS & THE INSIGHTS THEY HAVE GENERATED
Symposium at ERS 2019
Watch this symposium, recorded during the ERS Congress 2019, to learn more about how big tech companies are interested in its potential to improve SBD treatment.
Dr Carlos Nunez
Chief Medical Officer, Medical Affairs, ResMed
Looking for more information?
ResMed is pioneering the future of healthcare with smart devices and digital solutions.Learn more
Big data and CSA
Central Sleep Apnoea during CPAP therapy: first insights from a big data analysisLearn more